PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9458834-3 1998 ANG II also increased prostaglandin E2 (PGE2) production by the MTAL in a dose-dependent manner and exerted biphasic differential effects on 86Rb uptake, depending on the exposure time of the tubules to the peptide and the doses used. Rubidium-86 141-145 angiotensinogen Homo sapiens 0-6 9458834-4 1998 Low-dose ANG II (10(-11) M) increased 86Rb uptake by MTAL tubules after a "short-term" (15 min) challenge, whereas uptake was inhibited after a "long-term" (3 h) incubation period. Rubidium-86 38-42 angiotensinogen Homo sapiens 9-15 9458834-5 1998 High-dose ANG II (10(-6) M) inhibited MTAL 86Rb uptake, irrespective of incubation time. Rubidium-86 43-47 angiotensinogen Homo sapiens 10-16 9458834-6 1998 Uptake of 86Rb was inhibited by approximately 60% in MTAL tubules that were challenged for 3 h with ANG II. Rubidium-86 10-14 angiotensinogen Homo sapiens 100-106 9458834-8 1998 We conclude that ANG II regulates TNF production in the MTAL, an interaction that affects 86Rb uptake via an eicosanoid-dependent mechanism in this nephron segment. Rubidium-86 90-94 angiotensinogen Homo sapiens 17-23 1322364-5 1992 Angiotensin II caused rapid increases in both steady-state Na+, K(+)-ATPase activity (ouabain-sensitive 86Rb uptake) and intracellular [Na+]. Rubidium-86 104-108 angiotensinogen Homo sapiens 0-14 6328908-4 1984 AII also stimulated ouabain-sensitive 86Rb+ uptake by cultured aortic smooth muscle and brain microvessel cells. Rubidium-86 38-43 angiotensinogen Homo sapiens 0-3 366104-2 1978 Both phenylephrine and angiotensin II caused transient increases in 86Rb efflux from liver slices. Rubidium-86 68-72 angiotensinogen Homo sapiens 23-37